Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In Phase 2/3 trials, participants lost an average of 24-29% of body weight at the highest doses over 48-68 weeks
Calorie targets adjust based on labs, medications, and clinical response
Genetic alterations in Krebs cycle and its impact on cancer pathogenesis
Overall, GL-ME LLC presents itself as a knowledgeable entity in the health supplement market, dedicated to enhancing individual wellness journeys through the Gl-Me GLP-1 product
Key Facts A trial of 195 adults with obesity found that glucagon-like peptide-1 (GLP-1) receptor agonists, a class of drugs used to treat diabetes, resulted in reduced hip and spine bone mineral density when used without exercise compared to a placebo or exercise alone, researchers said
US$ 23.22
US$ 22.37
US$ 27.93
